Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

  Some of the factors driving the growth of the precision medicine market are the increased approval of drugs with companion diagnostic assays, cost-effective DNA profiling, rising cancer incidence rates, and the advent of data-driven healthcare. Furthermore, the growing use of “multi-omics” in research, as well as the penetration of high-throughput sequencing systems, is influencing the precision medicine landscape. In oncology, the number of targeted compounds in development for a given use has been expanding at an exponential rate.

  The desire for a personalized product has grown as the cost of drug discovery has risen in tandem with regulatory restrictions. Companion diagnostics appear to provide a set of tools as well as pertinent clinical and biological information.

Read more @ https://bit.ly/3In9tLf



Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe